Trial of Unani medicine in the patients of Fungal infection of skin

Phase 2

Not yet recruiting

• Conditions: Other specified local infections of the skin and subcutaneous tissue,

• Registration Number: CTRI/2020/04/024609
• Lead Sponsor: Aligarh Muslim University

Brief Summary

The purpose of this study is to determine and validate the safety and efficacy of Unani pharmacopeal formulation on the patients of fungal infection of the skin.   The Results of this study will be published in the Journals.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-03-31
• Study Start: 2020-04-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 104

Inclusion Criteria

Patients with sign and symptoms of Dermatomycoses.

Exclusion Criteria

• Patient of Tinea capitis, Tinea ungium,impaired liver function, impaired renal function,Hypersensitivity of drugs, Malignancy, Epilepsy.
• Patients on prolong medication for any systemic disorder,on systemic corticoseteroid, disease modyfiny agents.
• Patients with secondary infection or any other infective disorder requiring long term treatment.Alcohalics, Drug Addicts,Pregnant or Lactating mother.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Unani formulation will be effective in treating Dermatomycoses	08 weeks

Secondary Outcome Measures

Name	Time	Method
Unani formulation will relieve of the symptomps of Dermacomycoses	08 weeks

Trial Locations

Locations (1)

Ajmal Khan Tibbiya College and Hospital; 🇮🇳 Aligarh, UTTAR PRADESH, India

Ajmal Khan Tibbiya College and Hospital

🇮🇳Aligarh, UTTAR PRADESH, India

Dr Zamir Ahmad

Principal investigator

08475007594

drzamiramrohi@gmail.com